REYKJAVIK, Iceland Icelandic generic drug maker Actavis has appointed a new chief executive, Actavis said last week.
Actavis announced the appointment of former Ratiopharm leader Claudio Albrecht as CEO, effective immediately. Albrecht has worked in the generic drug industry for more than 20 years, having started with Sandoz in 1987. He began working for Ratiopharm in 2000 as global CEO and established pharmaceutical consultancy Cometh in 2008.
“I am delighted that we have attracted someone of Dr. Claudio Albrecht’s caliber to Actavis,” Actavis Group chairman Thor Bjorgolfsson said. “I am certain that the group will benefit considerably from his extensive leadership qualities. His experience and determination will help drive future growth in our great company.”